Envveno Medical Corporation (NVNO)

10:11 AM

Three-year VenoValve first-in-human trial data show high patency rate - Venous News

10:11 AM

09:57 AM

NVNO's VenoValve Shows Promising Three-Year Outcomes in Published Study | NVNO Stock News - GuruFocus

09:57 AM

09:54 AM

Three-Year VenoValve(R) First-in-Human Trial Data Published in t - GuruFocus

09:54 AM

09:53 AM

enVVeno Medical (NVNO) Reveals Promising Three-Year VenoValve Ou - GuruFocus

09:53 AM

08:50 AM

Three-Year VenoValve(R) First-in-Human Trial Data Published in the Annals of Vascular Surgery - ACCESS Newswire

08:50 AM

May 03, 2025

Geode Capital Management LLC Increases Stake in enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World

May 03, 2025

May 01, 2025

NVNO: Financial Position Supports Key Developments Ahead | NVNO Stock News - GuruFocus

May 01, 2025

May 01, 2025

enVVeno Medical (NVNO) Eyes Commercial Transition with VenoValve - GuruFocus

May 01, 2025

May 01, 2025

enVVeno Medical Reports First Quarter 2025 Financial Results and - GuruFocus

May 01, 2025

May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025

May 01, 2025

enVVeno Medical Reports First Quarter 2025 Financial Results and Reiterates Progress Toward VenoValve FDA Decision Expected in 2H24 - Eagle-Tribune

May 01, 2025

May 01, 2025

enVVeno Medical Reports Strong Q1 Financials with $38.9M War Chest for VenoValve FDA Launch - Stock Titan

May 01, 2025

Apr 29, 2025

enVVeno Medical Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - ACCESS Newswire

Apr 29, 2025

Apr 29, 2025

JPMorgan Chase & Co. Buys New Shares in enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World

Apr 29, 2025

Apr 23, 2025

VenoValve to be Featured During Presentation at the 47th Annual Charing Cross Symposium | NVNO Stock News - GuruFocus

Apr 23, 2025

Apr 23, 2025

VenoValve to be Featured During Presentation at the 47th Annual Charing Cross Symposium - Weatherford Democrat

Apr 23, 2025

Apr 21, 2025

enVVeno Medical Corp appoints CBIZ CPAs as new auditor By Investing.com - Investing.com South Africa

Apr 21, 2025

Apr 21, 2025

enVVeno Medical Corp appoints CBIZ CPAs as new auditor - Investing.com Australia

Apr 21, 2025

Apr 16, 2025

enVVeno Medical to Participate in a Live Virtual Investor Closing Bell Segment | NVNO Stock News - GuruFocus

Apr 16, 2025

Apr 16, 2025

enVVeno Medical to Participate in a Live Virtual Investor Closing Bell Segment - Weatherford Democrat

Apr 16, 2025

Apr 16, 2025

Live Today: enVVeno Medical Unveils Game-Changing Venous Valve Technology - Stock Titan

Apr 16, 2025

Apr 13, 2025

National Bank of Canada FI Takes $60,000 Position in enVVeno Medical Corporation (NASDAQ:NVNO) - The AM Reporter

Apr 13, 2025

Apr 07, 2025

enVVeno Medical Promotes Dr. Hamed Alavi to Senior Vice President and Chief Technology Officer - ACCESS Newswire

Apr 07, 2025

Apr 06, 2025

Financial Analysis: ClearPoint Neuro (NASDAQ:CLPT) vs. enVVeno Medical (NASDAQ:NVNO) - Defense World

Apr 06, 2025

Apr 03, 2025

NVNO stock touches 52-week low at $2.45 amid market challenges - Investing.com

Apr 03, 2025

Apr 01, 2025

We're Hopeful That enVVeno Medical (NASDAQ:NVNO) Will Use Its Cash Wisely - simplywall.st

Apr 01, 2025

Mar 31, 2025

The Impact of the VenoValve(R) on Patients with Primary and Secondary Chronic Venous Insufficiency (CVI) to be Presented at the Society for Clinical Vascular Surgery 52nd Annual Symposium - Weatherford Democrat

Mar 31, 2025

Mar 31, 2025

Virtu Financial LLC Buys Shares of 28,533 enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World

Mar 31, 2025

Mar 24, 2025

NVNO Completes Application for VenoValve's PMA, Shares Likely to Gain - MSN

Mar 24, 2025

Mar 13, 2025

VenoValve trial shows sustained patient benefits at 24 months - MSN

Mar 13, 2025

Mar 07, 2025

Sanctuary Advisors LLC Makes New Investment in enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World

Mar 07, 2025

Mar 03, 2025

enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25 - BioSpace

Mar 03, 2025

Feb 28, 2025

enVVeno Medical (NVNO) to Release Earnings on Thursday - MarketBeat

Feb 28, 2025

Feb 28, 2025

enVVeno Medical expects capital to fund company through several milestones - TipRanks

Feb 28, 2025

Feb 28, 2025

enVVeno Medical Files For Mixed Shelf Of Up To $100 MillionSEC Filing - TradingView

Feb 28, 2025

Feb 28, 2025

enVVeno Medical reports FY24 EPS ($1.27) vs. ($1.91) last year - TipRanks

Feb 28, 2025

Feb 28, 2025

NVNOEnvveno Medical Corporation Latest Stock News & Market Updates - StockTitan

Feb 28, 2025

Feb 28, 2025

EnVVeno Medical Reports Fourth Quarter and Year-End 2024 Financi - News Channel Nebraska

Feb 28, 2025

Feb 28, 2025

Can enVVeno's $43M Cash Runway Carry VenoValve Through FDA Approval? Clinical Data Shows 78% Success Rate - Stock Titan

Feb 28, 2025

Feb 27, 2025

enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of Marketing - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

enVVeno Medical (NVNO) Projected to Post Quarterly Earnings on Thursday - Defense World

Feb 27, 2025

Feb 26, 2025

enVVeno Medical to Participate in the Virtual Investor Closing Bell Series - ACCESS Newswire

Feb 26, 2025

Feb 25, 2025

enVVeno Medical (NASDAQ:NVNO) Shares Up 6.4%Here's Why - MarketBeat

Feb 25, 2025

Feb 20, 2025

enVVeno Medical to Present at the Ladenburg Thalmann 2022 Healthcare Conference - ACCESS Newswire

Feb 20, 2025